Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-24-016610

10% owner acquired 1,166,666 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC 10% owner 2024-02-16 Grant or award +1,166,666 $7.50 $8,749,995 4,438,790 I
Derivatives
Fairmount Funds Management LLC 10% owner 2024-02-16 Grant or award · Series B Convertible Preferred Stock +1,500 $7,500.00 $11,250,000 1,500 I
Loading xslF345X05/ownership.xml…